MONTREAL, QUEBEC--(Marketwire - June 13, 2008) - Ambrilia Biopharma Inc. (TSX: AMB) today announced that Dr. Philippe Calais, President and CEO, will present the Company and its projects at the BIO2008 International Convention to be held in San Diego, June 17-20. This presentation will take place on Thursday, June 19, at 10:30 am local time, in Room 5B.
